Hospital
Sanford Medical Center
Sanford Medical Center was paid $24.40M by Medicaid between Jan 2018 and Dec 2024, across 117 billing codes. Its largest line is J3490, Unclassified drugs — 75% of everything it billed.
33Billing provider infoSANFORD MEDICAL CENTER
SIOUX FALLS, SD 57105
SIOUX FALLS, SD 57105
33aNPI1821017880assigned 07/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$24.40M
24GClaims371,306
24DCodes billed117
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in South Dakota
Rank by total paid#1 of 17
Median peer was paid$547K
This provider vs. median45×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MORRISON, TONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,526 | $3.21M | |
| 2019 | 44,217 | $3.12M | |
| 2020 | 25,600 | $1.45M | |
| 2021 | 67,026 | $4.02M | |
| 2022 | 75,221 | $4.38M | |
| 2023 | 65,650 | $3.98M | |
| 2024incomplete | 46,066 | $4.24M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J3490 | Unclassified drugs | 75% | 88,118 | 24,445 | $18.29M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 6.6% | 107,765 | 41,506 | $1.62M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.3% | 8,994 | 8,268 | $803K |
| 80053 | Comprehensive metabolic panel | 2.9% | 4,769 | 4,466 | $719K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 36,943 | 3,239 | $451K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.5% | 16,330 | 2,802 | $355K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.4% | 6,944 | 6,204 | $337K |
| A9270 | Non-covered item or service | 1.2% | 24,644 | 2,310 | $300K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.0% | 969 | 911 | $254K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 208 | 187 | $230K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 572 | 560 | $145K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 2,949 | 2,752 | $118K |
105 more codes
| 76770 | <1% | 692 | $65K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 112 | $52K |
| G0008 | Administration of influenza virus vaccine | <1% | 4,923 | $51K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 141 | $45K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 716 | $40K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 8,659 | $39K |
| 93296 | <1% | 2,291 | $31K | |
| 74018 | <1% | 364 | $29K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,397 | $24K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 759 | $23K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 772 | $22K |
| A0434 | Specialty care transport (sct) | <1% | 82 | $21K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 332 | $21K |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 325 | $21K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,691 | $19K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,081 | $19K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 1,017 | $19K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 385 | $18K |
| Q3014 | Telehealth originating site facility fee | <1% | 2,301 | $17K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,806 | $17K |
| G0378 | Hospital observation service, per hour | <1% | 1,293 | $12K |
| 11721 | <1% | 891 | $12K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 210 | $11K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,322 | $10K |
| G0249 | Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests | <1% | 329 | $10K |
| 93325 | <1% | 1,391 | $9K | |
| 42830 | <1% | 23 | $8K | |
| J2704 | Injection, propofol, 10 mg | <1% | 5,037 | $8K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,081 | $8K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 254 | $6K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 353 | $6K |
| 90837 | Psychotherapy session, about an hour | <1% | 996 | $5K |
| 54161 | <1% | 15 | $5K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 63 | $5K |
| 97161 | <1% | 610 | $5K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,054 | $5K |
| 87631 | <1% | 12 | $4K | |
| 93971 | <1% | 331 | $4K | |
| 0124A | <1% | 558 | $3K | |
| 81001 | <1% | 167 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 15 | $3K |
| 93226 | <1% | 108 | $3K | |
| 97162 | <1% | 177 | $3K | |
| 64642 | <1% | 17 | $3K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,795 | $3K |
| 0054A | <1% | 265 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 191 | $2K |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 102 | $2K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 90 | $2K |
| 90480 | <1% | 336 | $1K | |
| 93970 | <1% | 60 | $1K | |
| 92134 | <1% | 26 | $1K | |
| G0009 | Administration of pneumococcal vaccine | <1% | 319 | $1K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 14 | $1K |
| 36416 | <1% | 90 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 203 | $1K |
| 97166 | <1% | 12 | $1K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 503 | $1K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 14 | $970.31 |
| 99453 | <1% | 34 | $919.18 | |
| 93225 | <1% | 50 | $915.12 | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 58 | $887.57 |
| 0004A | <1% | 263 | $840.83 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 95 | $825.31 |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 170 | $787.41 |
| 0001A | <1% | 40 | $737.23 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 44 | $718.73 |
| 93320 | <1% | 96 | $714.36 | |
| 80061 | Lipid panel | <1% | 50 | $664.74 |
| J7999 | Compounded drug, not otherwise classified | <1% | 255 | $651.13 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 97 | $630.47 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 55 | $620.64 |
| C1769 | Guide wire | <1% | 26 | $592.52 |
| 99454 | <1% | 44 | $581.95 | |
| 0002A | <1% | 22 | $551.22 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 17 | $528.30 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 64 | $382.51 |
| 84439 | <1% | 37 | $346.68 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 29 | $187.11 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 16 | $184.57 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 33 | $135.12 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 209 | $103.16 |
| 85610 | <1% | 23 | $57.90 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,569 | $18.69 |
| 90686 | <1% | 433 | $12.67 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 17 | $12.67 |
| 83605 | <1% | 16 | $11.57 | |
| 90662 | <1% | 299 | $10.12 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 249 | $0.00 |
| 83735 | 0% | 72 | $0.00 | |
| 90656 | 0% | 44 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 71 | $0.00 |
| C9290 | Injection, bupivacaine liposome, 1 mg | 0% | 15 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 12 | $0.00 |
| 84484 | 0% | 18 | $0.00 | |
| 83690 | 0% | 20 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 1,781 | $0.00 |
| 90671 | 0% | 79 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 169 | $0.00 |
| 91320 | 0% | 130 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 42 | $0.00 |
| 91300 | 0% | 20 | $0.00 | |
| 99152 | 0% | 14 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 14 | $0.00 |
| 95874 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORRISON, TONY (VICE PRESIDENT, REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | $50.18M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $47.45M |
| Sanford Bismarck | Bismarck, ND | $43.96M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $27.11M |
| FM Ambulance Service, INC | Fargo, ND | $23.80M |
| Sanford Medical Center | Sioux Falls, SD | $18.03M |
| Sanford Health Network | Worthington, MN | $7.58M |
| Sanford Clinic | Sioux Falls, SD | $6.04M |
| Sanford Clinic | Sioux Falls, SD | $5.45M |
| Sanford Healthcare Accessories, LLC | Fargo, ND | $4.79M |
| Sanford Health Network North | Thief River Falls, MN | $3.28M |
| Sanford Clinic | Sioux Falls, SD | $2.96M |
| Sanford Health Network | Jackson, MN | $2.81M |
| Sanford Clinic | Watertown, SD | $2.02M |
| Black Hills Orthopedic & Spine Center, INC. | Rapid City, SD | $1.71M |
| Sanford Health Network | Chamberlain, SD | $1.47M |
| Sanford Health Network | Vermillion, SD | $1.31M |
| Sanford Health Network | Luverne, MN | $1.27M |
| Sanford Medical Center Fargo | Pelican Rapids, MN | $1.01M |
| Sanford Medical Center Fargo | Mahnomen, MN | $994K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.